Furthermore, overexpression of NF-κB p52 or RelB in NHL cells also can reduce the inhibitory effect of DHI on the NHL cells (Figures 7c, d, e and f), indicating blockade of classical and alternative NF-κB pathway is involved in DHI-mediated growth inhibition of NHL cell lines. Here, NFKB1 is linked to non-Hodgkin lymphoma.